Interview: UK Initiative Bids To Boost Access To Cancer Clinical Trials
Fewer Than 50% Of Patients Told About Trials After Cancer Diagnosis
The Christie cancer hospital in Manchester has linked up with Innovative Trials to try and get more minority and socially-deprived communities into clinical studies.
You may also be interested in...
The biopharma industry has struggled to recruit patients into clinical trials that adequately reflect the diverse patient populations they hope to reach with new products. Failure to improve minority subgroup participation now will cost trial sponsors later.
The psoriasis market is a tough one for bimekizumab to crack but UCB head of immunology Emmanuel Caeymaex believes the clinical package and investment in promotion will see the IL-17A and IL-17F inhibitor topple its rivals.
It has taken almost two decades but it looks as though Erytech could get approval for eryaspase in the US in two indications next year – acute lymphoblastic leukemia and pancreatic cancer.